Concord Medical Services Holdings (CCM) EPS (Weighted Average and Diluted) (2009 - 2018)

Concord Medical Services Holdings has reported EPS (Weighted Average and Diluted) for 10 years, with the latest figure at -$0.45 in Q2 2018.

• For the quarter ending Q2 2018, EPS (Weighted Average and Diluted) fell 32.35% year-over-year to -$0.45; the trailing twelve-month figure through Dec 2025 stood at -$3.83 (up 17.38% YoY), and the FY2025 full-year result was -$0.1, up 68.75% from the prior year.
• EPS (Weighted Average and Diluted) for Q2 2018 stood at -$0.45, down from -$0.34 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $0.13 in Q2 2014, with the low at -$0.5 in Q4 2016.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.19 across 5 years, with a median of -$0.22 in 2014.
• The largest YoY upside for EPS (Weighted Average and Diluted) was 42.86% in 2014 against a maximum downside of 549.7% in 2014.
• Concord Medical Services Holdings' EPS (Weighted Average and Diluted) stood at -$0.22 in 2014, then slumped by 48.66% to -$0.33 in 2015, then plunged by 50.22% to -$0.5 in 2016, then surged by 32.29% to -$0.34 in 2017, then sank by 32.35% to -$0.45 in 2018.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.45 (Q2 2018), -$0.34 (Q2 2017), and -$0.5 (Q4 2016), per Business Quant data.